Clinuvel Pharmaceuticals Ltd
XMUN:UR9
Clinuvel Pharmaceuticals Ltd
XMUN:UR9
Price:
5.076
EUR
Market Closed
Market Cap:
€766.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Clinuvel Pharmaceuticals Ltd
XMUN:UR9
|
AU |
|
C
|
Crane Co
NYSE:CR
|
US |
|
Guillemot Corporation SA
PAR:GUI
|
FR |
|
Adairs Ltd
ASX:ADH
|
AU |
|
S
|
SCI Electric PCL
SET:SCI
|
TH |
|
G
|
Genufood Energy Enzymes Corp
OTC:GFOO
|
US |
|
A
|
Accor SA
F:ACR
|
FR |
|
S
|
Southern Seed Corp
VN:SSC
|
VN |
|
K
|
Kratos Energy & Infrastructure Ltd
BSE:501261
|
IN |
|
N
|
Northern Shield Resources Inc
OTC:NSHRF
|
CA |
|
N
|
Nissin Foods Holdings Co Ltd
SWB:NF2
|
JP |
|
Sportsmans Warehouse Holdings Inc
NASDAQ:SPWH
|
US |
|
N
|
Novartis AG
SWB:NOTA
|
CH |
|
R
|
Randstad NV
DUS:RSH
|
NL |
|
A
|
Arbor Realty Trust Inc
F:OWQ
|
US |
|
Relx PLC
LSE:REL
|
UK |
Multiples-Based Value
The Multiples-Based Value for 
Clinuvel Pharmaceuticals Ltd (UR9) under the Base Case is hidden
EUR.
Compared with the current market price of 5.076 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
UR9 Multiples-Based Value
LOCKED